Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary

被引：22

作者：

Chudecka-Głaz A. ^{[1
]}

Rzepka-Górska I. ^{[1
]}

Kosmowska B. ^{[1
]}

机构：

[1] Dept. Gynecol. Surg. Oncol. A., Pomeranian Medical University, 70-111 Szczecin

来源：

Archives of Gynecology and Obstetrics | 2004年 / 270卷 / 3期

关键词：

Epithelial ovarian cancer; Gonadotropins; Ovarian cyst fluid analysis;

D O I：

10.1007/s00404-003-0519-4

中图分类号：

学科分类号：

摘要：

Objectives: The aim of this work was to determine gonadotropin (LH, FSH) levels in serum and cyst fluid in various type of ovarian epithelial neoplasms (benign, borderline, malignant) and to compare them with levels in benign cysts. Additionally we decided to estimate if there were some significant correlations between serum and ovarian cyst fluid in gonadotropin levels in all investigated groups. Materials and methods: The study group included 74 patients before (n=36) and after (n=38) menopause, divided into four groups depending on the histopathologic diagnosis. Serum and cyst fluid levels of LH and FSH were determined in all patients. Results: We found statistically significant differences concerning LH and FSH levels in serum and cyst fluid between malignant and borderline tumors, between malignant tumors and benign cystadenomas and between malignant tumors and non-neoplastic cysts. We also found statistically significant correlations between serum and cyst fluid as to FSH and LH levels in patients with borderline tumors. There were no statistically significant correlations between serum and cyst fluid as to FSH and LH levels in patients with malignant epithelial tumors (group 1) and in patients with benign cystadenomas (group 3). Conclusions: High FSH and LH levels in cyst fluid of malignant epithelial tumors of the ovary are in line with the gonadotropin theory of tumor growth. Simultaneous determination of various types inhibin levels appears to be an interesting topic for our future research. © Springer-Verlag 2003.

引用

页码：151 / 156

页数：5

共 17 条

[1]

Blaakaer J., Micic S., Morris I.D., Hording U., Bennett P., Toftager-Jansen K., Et al., Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors, Eur J Obstet Gynecol Reprod Biol, 52, pp. 105-110, (1993)

[2]

Blaakaer J., Baeksted M., Micic S., Albrectsen P., Rygaard J., Bock J., Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the W<sub>x</sub>/W<sub>v</sub> genotype, Biol Reprod, 53, pp. 775-779, (1995)

[3]

Chudecka-Glaz A., Rzepka-Gorska I., Kosmowska B., Glaz C., The levels of selected hormones in serum and in ovarian cyst fluid at girls and young women, Ginekol Pol, 70, pp. 236-241, (1999)

[4]

Cramer D.W., Barbieri R.L., Muto M.D., Kelly A., Brucks J.P., Harlow B.L., Characteristics of women with a family history of ovarian cancer, Cancer, 74, pp. 1318-1322, (1994)

[5]

Emons G., Weis S., Grundker C., Schultz K.D., LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer, Eur J Endocrinol, 142, pp. 665-670, (2000)

[6]

Irmer G., Burger C., Muller R., Ortmann O., Peter U., Kakar S.S., Et al., Expression of the messenger RNAs for luteinizing releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma, Cancer Res, 55, pp. 817-822, (1995)

[7]

Ivarsson K., Sundfeldt K., Brannstrom M., Hellberg P., Janson P.O., Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells, Hum Reprod, 16, pp. 18-23, (2001)

[8]

Kramer S., Leeker M., Jager W., Gonadotropin levels in ovarian cyst fluids: A predictor of malignancy?, Int J Biol Markers, 13, pp. 165-168, (1998)

[9]

Kurbacher C.H.M., Jager W., Kurbacher J.A., Bittl A., Wildt L., Lang N., Influence of human luteinizing hormone cell growth and CA 125 secretion of primary epithelial ovarian carcinoma in vitro, Tumor Biol, 16, pp. 374-384, (1995)

[10]

Kuroda H., Mandai M., Konishi I., Yasuichiro Y., Tsuruta Y., Hamid A., Et al., Human chorionic gonadotropin (hCG) inhibits cisplatin-inducted apoptosis in ovarian cancer cells: Possible role of up-regulation of insuline-like growth factor-1 by hCG, Int J Cancer, 76, pp. 571-578, (1998)

← 1 2 →